Case: Patents/Procedure (N.D. Ill.)

Feb. 28, 2025, 9:15 PM UTC

A federal district court in Illinios granted in part and denied in part EVER Valinject GmbH, Shanghai Haoyuan Chemexpress Co. Ltd., Medchemexpress LLC, and Ruyuan HEC Pharm Co. Ltd.'s motion to dismiss Janssen Products LP’s action seeking a declaratory judgment of infringement based on EVER’s submission of a new drug application to the FDA for approval to sell a generic version of Yondelis® to treat rare forms of soft-tissue cancer. The court denied HC’s and Ruyuan’s motions to dismiss for lack of personal jurisdiction, severed MCE from the suit and transferred the case as to MCE to the district of ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.